PAPER David S, Costa AS, Hohenfeld C, Romanzetti S, Mirzazade S, Pahl J, Haberl L, Schneider KM, Kilders A, Eggermann T, Trautwein C, Hildebrand F, Schulz JB, Reetz K, Haeger A
SEARCH RESULTS
345052 RESULTS
PAPER Ong J, Sasaki K, Ferdousi F, Suresh M, Isoda H, Szele FG
Senescence Accelerated Mouse-Prone 8: a Model of Neuroinflammation and Aging with Features of Sporadic Alzheimer's disease.
Stem Cells. 2025 Jan 15; Epub 2025 Jan 15 PubMed.PAPER Chauveau L, Landeau B, Dautricourt S, Turpin AL, Delarue M, Hébert O, de La Sayette V, Chételat G, de Flores R
Anterior-temporal network hyperconnectivity is key to Alzheimer's disease: from ageing to dementia.
Brain. 2025 Jan 15; Epub 2025 Jan 15 PubMed.PAPER Didcote L, Vitoratou S, Al-Chalabi A, Goldstein LH
Predicting ALS informant distress from cognitive and behavioural change in people with ALS.
J Neurol. 2025 Jan 15;272(2):144. PubMed.PAPER Zhao C, Li T, Hao S, Zhao L, Han Y, Cai Y
Dysregulation of the molecular clock by blood-borne factors in Alzheimer's disease patients.
J Neurol. 2025 Jan 15;272(2):121. PubMed.PAPER Iqbal Z, El Hamamy A, Le NM, Ranjan A, Zhang Y, Qi L, Manwani B, Tan C, McCullough LD, Li J
Targeting Astrogliosis in the Retrotrapezoid Nucleus: A Novel Approach to Ameliorate Respiratory Dysfunction and Alzheimer's Pathology in Mice.
Aging Dis. 2025 Jan 9; Epub 2025 Jan 9 PubMed.PAPER Moncer R, Hajji H, Naija S, Ben Amor S, Jemni S, Ben Saad H
Effects of Yoga-Like Exercises on Mild and Moderate Alzheimer Disease: A Randomized Controlled Trial Protocol.
Tunis Med. 2025 Jan 5;103(1):58-64. PubMed.PAPER Jutten RJ, Ho EH, Karpouzian-Rogers T, van Hulle C, Carlsson C, Dodge HH, Nowinski CJ, Gershon R, Weintraub S, Rentz DM
Computerized cognitive testing to capture cognitive decline in Alzheimer's disease: Longitudinal findings from the ARMADA study.
Alzheimers Dement (Amst). 2025;17(1):e70046. Epub 2025 Jan 14 PubMed.PAPER Chua J, Li C, Antochi F, Toma E, Wong D, Tan B, Garhöfer G, Hilal S, Popa-Cherecheanu A, Chen CL, Schmetterer L
Utilizing deep learning to predict Alzheimer's disease and mild cognitive impairment with optical coherence tomography.
Alzheimers Dement (Amst). 2025;17(1):e70041. Epub 2025 Jan 14 PubMed.PAPER Blotenberg I, Wittström F, Michalowsky B, Platen M, Wucherer D, Teipel S, Hoffmann W, Thyrian JR
Modifiable risk factors and symptom progression in dementia over up to 8 years-Results of the DelpHi-MV trial.
Alzheimers Dement (Amst). 2025;17(1):e70050. Epub 2025 Jan 14 PubMed.PAPER Yoo J, Lee J, Ahn B, Han J, Lim MH
Multi-target-directed therapeutic strategies for Alzheimer's disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition.
Chem Sci. 2025 Jan 6; Epub 2025 Jan 6 PubMed.PAPER Barnes LL, Mella LF, Lopes FD, Dos Santos A, Dalgalarrondo P
Neuropsychiatric symptoms and specific cognitive domains in mild cognitive impairment.
Dement Neuropsychol. 2024;18:e20240187. Epub 2025 Jan 13 PubMed.PAPER Mandal PK, Maroon JC, Guha Roy R, Patira R, Gogniat MA, Sindhu B
The Missing Link in Antiamyloid Therapy.
ACS Chem Neurosci. 2025 Jan 14; Epub 2025 Jan 14 PubMed.PAPER Li VO, Han Y, Kaistha T, Zhang Q, Downey J, Gozes I, Lam JC
DeepDrug as an expert guided and AI driven drug repurposing methodology for selecting the lead combination of drugs for Alzheimer's disease.
Sci Rep. 2025 Jan 15;15(1):2093. PubMed.PAPER Wu H, Gu X, Liu S, Wang P, Lu H, Guan Y, Shi Z, Ji Y
ApoE Genotype, Age, and Cognitive Decline in Old Chinese Individuals Without Dementia: A Population-Based Study With Five-Year Follow-Up.
Int J Geriatr Psychiatry. 2025 Jan;40(1):e70045. PubMed.Current Filters
No filters selected